Issue link: https://beckershealthcare.uberflip.com/i/498463
26 Becker's 13th Annual Spine, Orthopedic and Pain Management-Driven ASC Conference + The Future of Spine - call (800) 417-2035 in adult stem cell therapeutics, is one that Dr. Jones received himself in Kyoto, Japan. He found the spinal infusion procedure so effective that he decided to incorporate it into his spine practice. J. Patrick Johnson, MD (Cedars-Sinai Medical Center, Los Angeles). Dr. Johnson's research in- terests include biologic stem cell repair of spinal cord injuries, and has published several articles in professional journals. He previously served as the director of the Cedars-Sinai Institute for Spi- nal Disorders. Now, he serves as a neurosurgeon within the Cedars-Sinai Spine Center. Robert Johnson, MD (Neurological Associates of San Antonio). Dr. Johnson completed research and testing on the efficacy of point of care adult stem cell therapies in spine surgery, in which the patient's own bone marrow cells help bone growth in spinal fusion procedures. Dr. Johnson presented his findings at the 2010 Annual Stem Cell Summit in New York. He believes the use of autologous stem cells will revolutionize medical care and prevention of spinal disorders. Adam S. Kanter, MD (University of Pitts- burgh). Dr. Kanter is the principal investigator in several research studies examining stem cell-de- rived biologics to induce spinal fusion. He focuses on minimally invasive procedures and provides editorial service to several peer-reviewed journals. He has a special interest in experimental therapies for spinal cord regeneration. Kee Kim, MD (UC Davis Health System, Sacra- mento). Dr. Kim is the chief of spinal neurosur- gery at UC Davis and co-director of the UC Davis Spine Center. Dr. Kim is also the principal investi- gator for the Mesoblast trials at UC Davis as well as a parallel study where patients with advanced disc degeneration who had undergone removal of their cervical disc were injected with stem cells to promote vertebrae fusion. Jeffrey Kleiner, MD (The Medical Center of Au- rora, Aurora, Colo.). Dr. Kleiner was among the first spine surgeons to perform a discectomy in the United States using adult stem cells to help re- pair a patient's lower back in 2008. He partnered with the Colorado-based company Regenerative Sciences to perform the surgery. For the proce- dure, surgeons harvest stem cells from the patient and culture them before placing them into the pa- tients' spines during minimally invasive surgery. Carl Lauryssen, MD (Olympia Medical Center, Los Angeles). Dr. Lauryssen was among the first neurosurgeons in the country to inject stem cells into a human spinal cord as part of an FDA trial. He serves as the co-director of spine research and development and lead spine surgeon at Olym- pia Medical Center in Los Angeles. He has been awarded the young investigator award twice from the American Association of Neurological Sur- geons for his work with cervical disorders and stem cell research. Albert Lee, MD (Tallahassee Neurological Clin- ic). Dr. Lee is the principal investigator of the Mesoblast Disc Repair clinical trail at Tallahas- see Neurological Clinic, which will determine the safety of the single injection of allogenic mesen- chymal precursor adult cells. The cells are injected into symptomatic lumbar intervertebral discs to treat pain related to degenerative disc disease in the lumbar spine. Allen D. Levi, MD (University of Miami Health System). Dr. Levi is the chief of neurosurgery at the University of Miami Hospital and chief of neurospine services at Jackson Memorial Hospi- tal. Dr. Levi oversees several ongoing clinical tri- als and is actively researching treatment for spinal cord injury, including cellular transplantation of Schwann cells and stem cells. Robert Masson, MD (NeuroSpine Institute, Or- lando). Dr. Masson founded his practice and is an international consultant for stem cell use in spinal injury. He advocates for spine patient prehabilita- tion and invented the iMAS surgical symphony for the interpedicular minimal access procedures in the lumbosacral spine. Chris Meyer, MD (Houston Orthopedic & Spine Hospital, Bellaire, Texas). Dr. Meyer is at the forefront of using stem cell therapy for regenerat- ing tissue and has extensive experience harvesting adult stem cells during routine spine procedures to treat back pain. The bone marrow is concen- trated to the desired level for healing. Isaac L. Moss, MD (University of Connecticut Health Center, Farmington). Dr. Moss is a spine surgeon at New England Musculoskeletal In- stitute of the University of Connecticut Health Center. He has a professional interest in mini- mally invasive spine surgery and treating a vari- ety of spinal conditions. In addition to his medi- cal degree, Dr. Moss earned a master's degree in biomedical engineering and has been involved in developing novel biologic therapies for interver- tebral disc degeneration. John O'Toole, MD (Rush University Medical Center, Chicago). Dr. O'Toole is an assistant pro- fessor and attending physician in the department of neurosurgery at Rush University Medical Cen- ter. Dr. O'Toole has a special interest in transla- tional application of spinal biologics and the de- velopment of new spinal surgery techniques and devices. Burak Ozgur, MD (Hoag Neurosciences Insti- tute, Newport Beach, Calif.). Dr. Ozgur has a strong interest in stem cell research, spinal bio- mechanics and minimally invasive spine surgery development. Dr. Ozgur authored more than 27 articles in peer-reviewed publications, and com- pleted a combined orthopedic and neurosurgical spine surgery fellowship at the University of Cali- fornia San Diego Medical Center. John Peloza, MD (Texas Back Institute, Pla- no). Dr. Peloza was one of the first spine sur- geons and clinical researchers in Dallas to use mesenchymal stem cells to treat degenerative disc disease. He has been active in using biologic solu- tions to promote disc and joint healing. Dr. Peloza is a pioneer in minimal access spinal surgery and was instrumental in launching the SEXTANT, MET-Rx and MAVERICK total disc replacement. Todd Peters, MD (Todd Peters MD, Newport Beach, Calif.). Dr. Peters is focused on minimally invasive surgical disc innovations and next gener- ation orthopedic products using human protein and growth factor materials for bone and tissue regeneration. He is the director of orthopedic and minimally invasive spine surgery at ONE Brain & Spine Center. Kenneth Pettine, MD (The Spine Institute, Loveland, Colo.). Dr. Pettine performed the first Mesoblast procedure as part of the Phase 2 clini- cal trial for the company's adult Mesenchymal Precursor Cell product for lower back pain and degenerative disc disease. He has participated in two FDA studies involving biologics to treat dis- cogenic low back pain. He holds three patents for his technology and is a member of the North American Spine Society. Kevin Rahn, MD (Fort Wayne Orthopedics, Fort Wayne, Ind.). Dr. Rahn is actively involved in stem cell research and uses motion preservation techniques and laser procedures when treating his patients. Along with his colleague at Fort Wayne Orthopedics Robert Shugart, MD, Dr. Rahn is researching the effectiveness of injecting mes- enchymal precursor stem cells into the center of 13th Annual Spine, Orthopedic and Pain Management-Driven ASC Conference + The Future of Spine June 11-13, 2015 • Westin Michigan Avenue Hotel • Chicago, IL 90+ Surgeons Speaking & 108 Sessions • Key Note Speakers: Deion Sanders, Billy Beane and Bill Walton For more information, visit www.beckersspine.com or call (800) 417-2035.